Srilatha Edupuganti

Contact Information:

Phone: 404-712-1434

Email: sedupug@emory.edu

View Emory directory entry

School/Division:

Assoc Professor

SOM: Medicine: Infectious Dis

School Of Medicine

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 17

  1. 1
  2. 2

Article

DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial

by Julie E. Ledgerwood; Abbie R. Bellamy; Robert Belshe; David I. Bernstein; Srilatha Edupuganti; Shital M. Patel; Phyllis Renehan; Thad Zajdowicz; Richard Schwartz; Richard Koup; Robert T. Bailer; Galina V. Yamshchikov; Mary E. Enama; Uzma Sarwar; Brenda Larkin; Barney S. Graham; Nadine Rouphael

2015

Article

Biphasic Zika Illness With Rash and Joint Pain.

by Srilatha Edupuganti; Muktha S. Natrajan; Nadine Rouphael; Lilin Lai; Yongxian Xu; Matthew Feldhammer; Charles Hill; Shital M. Patel; Sara Jo Johnson; Mary Bower; Rodion Gorchakov; Rebecca Berry; Kristy O. Murray; Mark Mulligan

2017

Article

Innate, T-, and B-Cell Responses in Acute Human Zika Patients

by Lilin Lai; Nadine Rouphael; Yongxian Xu; Muktha Natrajan; Allison Beck; Mari Hart; Matthew Feldhammer; Amanda Feldpausch; Charles Hill; Henry Wu; Jessica K. Fairley; Pamela Lankford-Turner; Nicole Kasher; Patrick Rago; Yijuan Hu; Srilatha Edupuganti; Shital M. Patel; Kristy O. Murray; Mark Mulligan

2018

Article

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.

by Mark Mulligan; David I. Bernstein; Sharon Frey; Patricia Winokur; Nadine Rouphael; Nadine Rouphael; Michelle Dickey; Srilatha Edupuganti; Paul Spearman; Edwin Anderson; Irene Graham; Diana L. Noah; Brian Mangal; Sonnie Kim; Heather Hill; first name last name; Jenifer Whitaker; William Emery; Allison Beck; Kathy Stephens; Brooke Hartwell; Melinda Ogilvie; Nayoka Rimann; Eileen Osinski; Ellen Destefano; Theda Gajadhar; Amanda Strudwick; Karen Pierce; Lilin Lai; Ling Yue; Dongli Wang; Carl Ying; Amy Cline; Tara Foltz; Nancy Wagner; Geraldine Dull; Thomas Pacatte; Barbara Taggart; Valerie Johnson; Logan Haller; Candi Looney; Shixiong Li; Megan May; Bridgette Myers; Rachel May; Lawanda Parker; Nertaissa Cochran; Donna Bowen; Michelle Bell; Jeffery Scoggins; Angela Burns; Claire Stablein; Mark Wolff; Bernadette Jolles; Brenda Leung; Linda Lambert; Shy Shorer; Wendy Buchanan; Suzanne Murray; Soju Chang; Richard Gorman

2014

Article

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

by Gui-Mei Li; Christopher Chiu; Jens Wrammert; Megan McCausland; Sarah F. Andrews; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Xinyan Qu; Srilatha Edupuganti; Mark Mulligan; Suman R. Das; Jonathan W. Yewdell; Aneesh K Mehta; Patrick C. Wilson; Rafi Ahmed

2012

Article

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)

by Jonathan D. Fuchs; Ian Frank; Marnie L. Elizaga; Mary Allen; Nicole Frahm; Nidhi Kochar; Sue Li; Srilatha Edupuganti; Spyros A. Kalams; Georgia D. Tomaras; Rebecca Sheets; Michael Pensiero; Marc A. Tremblay; Terry J. Higgins; Theresa Latham; Michael A. Egan; David K. Clarke; John H. Eldridge; Mark Mulligan; Nadine Rouphael

2015

Article

Recognition of influenza H3N2 variant virus by human neutralizing antibodies.

by Sandhya Bangaru; Travis Nieusma; Nurgun Kose; Natalie Thornburg; Jessica A. Finn; Bryan. S Kaplan; Hannah G. King; Vidisha Singh; Rebecca M. Lampley; Gopal Sapparapu; Alberto Cisneros; Kathryn Edwards; James C. Slaughter; Srilatha Edupuganti; Lilin Lai; Juergen A. Richt; Richard J. Webby; Andrew B. Ward; James E. Crowe

2016

Article

Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials.

by Peter B. Gilbert; Michal Juraska; Allan C. deCamp; Shelly Karuna; Srilatha Edupuganti; Nyaradzo Mgodi; Deborah J. Donnell; Carter Bentley; Nirupama Sista; Philip Andrew; Abby Isaacs; Yunda Huang; Lily Zhang; Edmund Capparelli; Nidhi Kochar; Jing Wang; Susan H. Eshleman; Kenneth H. Mayer; Craig A Magaret; John Hural; James G Kublin; Glenda Gray

2017